NSN 6505-01-653-1569 · NIIN 016531569 · FSC 6505
NO DASHES 6505016531569
In Stock
DANTROLENE SODIUM FOR INJECTION
Drugs and Biologicals
Technical characteristics
9 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| AGXW | PHYSICAL FORM | POWDER |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | MILLIGRAMS OF ACTIVE INGREDIENT 250.0 |
| AJCN | PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| CSLZ | USUAL DOSE | 2.5 MG/KG ADMINISTERED INTRAVENOUSLY OVER A PERIOD OF AT LEAST 1 MINUTE, STARTING APPROXIMATELY 75 MINUTES PRIOR TO SURGERY |
| FEAT | SPECIAL FEATURES | DANTROLENE SODIUM 250MG FOR RECONSTITUTION WITH 5ML STERILE WATER FOR INJECTION; (WITHOUT A BACTERIOSTATIC AGENT); STORE UNRECONSTITUTED PRODUCT AT 20 TO 25 DEGREES CELSIUS (68-77 DEGREES FAHRENHEIT) - USP CONTROLLED ROOM TEMPERATURE; AVOID EXPOSURE TO LIGHT; MUST USE THE CONTENTS OF THE VIAL WITHIN 6 HOURS AFTER RECONSTITUTION. |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS DANTROLENE SODIUM ACTIVE INGREDIENT 250.0 |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CSGS | ADMINISTRATION | INTRAVENOUS |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | DANTROLENE SODIUM INJECTION 250MG |